Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies Inc. reports developments for a contract development and manufacturing organization focused on single-use and single-patient medical devices. Company news commonly covers quarterly and annual results, non-GAAP measures such as adjusted EBITDA and adjusted EPS, program ramps, backlog commentary, acquisition integration, and manufacturing capacity tied to medical-device customers.
Updates also include customer supply agreements, new program launches, investor conference participation, and governance matters such as executive succession planning. The company's products and components are used across medical device, wound care, infection prevention, minimally invasive surgery, wearable, orthopedic soft-goods, and orthopedic implant-packaging applications.
UFP Technologies (NASDAQ:UFPT) has announced two strategic acquisitions to enhance its medical device manufacturing capabilities: Universal Plastics & Engineering Company (UNIPEC) and Techno Plastics Industries (TPI).
UNIPEC, based in Maryland, specializes in precision thermoformed and heat-sealed polymer components for Class III implantable medical devices, with $5 million in revenue and $2 million in EBITDA. TPI, located in Puerto Rico, focuses on precision thermoplastic injection-molded components, generating $10 million in revenue and $1 million in EBITDA.
The acquisitions strengthen UFP's capabilities in tight tolerance film components and thermoplastic molding, particularly complementing their Welch Fluorocarbon operation and DAS business in the Dominican Republic. The deals were funded through available cash and existing credit facilities.
UFP Technologies (NASDAQ:UFPT) has announced its participation in the CJS Securities 25th Annual Summer Conference. Mitchell Rock, President, and Ron Lataille, Senior Vice President & CFO, will deliver a presentation and conduct one-on-one investor meetings at the event scheduled for Thursday, July 10, 2025.
UFP Technologies (NASDAQ: UFPT), a designer and manufacturer of medical device components and sterile packaging solutions, has scheduled its first quarter 2025 financial results announcement for May 6, 2025, before market opening.
The company will host a conference call at 10:00 AM Eastern Time on the same day to discuss the Q1 2025 results. Investors can join through:
- Toll-Free: 1-888-243-4451
- International: 1-412-542-4135
A live webcast will be available at www.ufpt.com, with a replay accessible afterward on the company's Investor Relations website at ufpt.com/investors/.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical market components and packaging, has announced its participation in the upcoming KeyBanc Capital Markets Healthcare Forum. The virtual event will feature presentations from the company's leadership, including Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille, scheduled for March 18, 2025, at 10:30 AM ET.
UFP Technologies (UFPT) reported record financial results for 2024, with net income rising 31.3% to $59.0 million and adjusted net income growing 32.5% to $67.6 million. Net sales increased 26.1% to $504.4 million compared to $400.1 million in 2023.
For Q4 2024, the company reported net income of $16.4 million (up 41.1%) and sales of $144.1 million (up 41.9%) compared to the same period in 2023. The company's MedTech segment showed particularly strong growth, with Q4 sales increasing 48.6% to $132.7 million and full-year sales rising 30.2% to $450.8 million.
CEO R. Jeffrey Bailly highlighted strong performance from newly acquired companies and noted expansion of operations in the Dominican Republic to accommodate business growth. The company anticipates two major programs launching in the second half of 2025 and expects strong cash flow to help reduce debt and position for future acquisitions.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical devices, sterile packaging, and engineered custom products, has announced its upcoming financial disclosure schedule. The company will release its fourth quarter and year-end 2024 financial results on Tuesday, February 25, 2025. This announcement pertains to the financial period ending December 31, 2024.
UFP Technologies (UFPT), a specialized manufacturer focusing on medical market components and packaging, has announced its participation in the CJS Securities 25th Annual "New Ideas for the New Year" Virtual Conference. The company's presentation is scheduled for January 14, 2025, at 8:45 AM ET.
Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will represent the company at the conference, where they will present and host one-on-one investor meetings. The event provides an opportunity for investors to learn more about UFP Technologies' innovative designs and custom manufacturing capabilities in the medical sector.